← Mechanisms of action
Lymphocytes
CELL-LINE
Drugs acting on this target (25)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| irradiated donor lymphocyte | Immunity, passive | experimental | Cell therapy | Lymphocytes immunity, passive |
| AMG-994 | Inhibitor | experimental | mAb | Lymphocytes inhibitor |
| BL-M02D1 | Inhibitor | experimental | mAb | Lymphocytes inhibitor |
| shr-1905 | Inhibitor | experimental | mAb | Lymphocytes inhibitor |
| activated marrow infiltrating lymphocytes | Supplementation | experimental | Cell therapy | supplementation - lymphocytes |
| autologous lymphocytes | Supplementation | experimental | Cell therapy | supplementation - lymphocytes |
| autologous plasmablasts | Supplementation | experimental | Cell therapy | supplementation - lymphocytes |
| autologous T cell memory cells | Supplementation | experimental | Cell therapy | supplementation - lymphocytes |
| cd34+ cells enriched with mnv-bld | Supplementation | experimental | Cell therapy | Lymphocytes supplementation |
| cd34+ hscs transduced with the lentivirus vector, vsv-g pseudotyped cl20-4i-ef1α-hγc-opt | Supplementation | experimental | Cell therapy | supplementation - lymphocytes |
| cd4+ t-cell-depleted haploidentical hematopoietic cells | Supplementation | experimental | Cell therapy | supplementation - lymphocytes |
| cda-2 | Supplementation | experimental | Biological | Lymphocytes supplementation |
| cg0070 | Supplementation | experimental | Biological | Lymphocytes supplementation |
| cord blood expanded with um171 | Supplementation | experimental | Cell therapy | supplementation - lymphocytes |
| gp96 | Supplementation | experimental | Biological | Lymphocytes supplementation |
| human t lymphoid progenitor | Supplementation | experimental | Cell therapy | supplementation - lymphocytes |
| il2rg gene into the blood forming stem cells (cd34+ cells) | Supplementation | experimental | Cell therapy | supplementation - lymphocytes |
| lymphocytes | Supplementation | experimental | Cell therapy | supplementation - lymphocytes |
| peripheral blood lymphocytes | Supplementation | experimental | Cell therapy | supplementation - lymphocytes |
| rp-l201 | Supplementation | experimental | Cell therapy | supplementation - lymphocytes |
| tcr alfa beta t cell depletion | Supplementation | experimental | Cell therapy | supplementation - lymphocytes |
| tyf-il-2rg gene-modified autologous stem cells | Supplementation | experimental | Cell therapy | supplementation - lymphocytes |
| allogenic t cell-depleted hematopoietic stem cells | Tissue restoration | experimental | Cell therapy | tissue restoration - lymphocytes |
| autologous cytokine induced killer cells | Tissue restoration | experimental | Cell therapy | tissue restoration - lymphocytes |
| t cell depleted hematopoietic stem cells | Tissue restoration | experimental | Cell therapy | tissue restoration - lymphocytes |